|Home | About | Journals | Submit | Contact Us | Français|
Anyone in the neuro-oncology profession may submit to the journal announcements of meetings, conferences, and funding opportunities of interest to colleagues. Please send announcements to Oliver Bögler, Ph.D., Department of Neurosurgery and Hermelin Brain Tumor Center, 2799 West Grand Boulevard, Detroit, MI 48202, USA (Telephone: 313-916-7293; E-Fax: 425-732-8379; E-mail: gro.cno-oruen-cos@swenyteicos).
Correspondence to the Society should be sent to Society for Neuro-Oncology, Post Office Box 890886, Houston, TX 77289-0886, or in care of Jan Esenwein, 4617 Birch Street, Bellaire, TX 77401-5509, USA (Telephone: 713-349-0952; Fax: 832-201-8129; E-mail: gro.cno-oruen-cos@naj or gro.cno-oruen-cos@pihsrebmem).
The Society for Neuro-Oncology gratefully acknowledges the pro bono accounting services performed by William M. Shields and Associates, 8980 Lakes at 610 Drive, Houston, TX 77054, USA. Since SNO was founded in 1995, Mr. Shields and members of his firm have provided advice and each year prepared our Form 990 (Return of Organization Exempt from Income Tax). In the past year, they also took on oversight of our State and Federal Payroll reporting. The valuable services they have provided to our organization, at no cost to us, are very much appreciated.
Brain Tumor Network, the professionals’ resource for advancing quality of life, is seeking grant proposals from researchers throughout the United States and Canada who are studying quality of life in neuro-oncology patients and families. Funding for two awards is provided by the American Brain Tumor Association and by the Tim & Tom Gullikson Foundation. Applications and information are available at www.braintumornetwork.org.
In June 2004, NBTF was pleased to provide research funding to the following researchers:
Andrew Bryce Pediatric Grant: $25,000
William C. Broaddus, M.D., Ph.D., Virginia Commonwealth University
Project Title: Use of Phosphoinositide Analogues to Enhance Chemosensitivity: A Novel Adjuvant Chemotherapeutic for Medulloblastoma
Joan Riordan Quality of Life Grant: $20,000
Denise Correa, Ph.D., ABPP-CN, Memorial Sloan-Kettering Cancer Center
Project Title: Long-Term Cognitive Outcome in Low Grade Glioma Patients
Oligodendroglioma Grants: $50,000
David Eisenstat, M.D., University of Manitoba
Project Title: Hypoxia and the Death Gene BNIP3 in Oligodendroglioma
Catherine L. Nutt, Ph.D., Massachusetts General Hospital
Project Title: Molecular Profile-Based Development of Accurate Immunohistochemical Markers for Human Oligodendrogliomas
Steven J. Bryant Research Grant: $25,000
Maciej S. Lesniak, M.D., The University of Chicago,
Project Title: IL13R-alpha2 Peptide Vaccine Against Glioma
ABC2 and the NBTF have partnered to fund an epidemiology study being conducted at the University of California at San Francisco entitled “Evaluation of non-synonymous coding single nucleotide polymorphisms (SNPs) in relation to glioblastoma multiforme (GM) prognosis and etiology.” This population-based study, led by Dr. Margaret Wrensch, examines the genetics of glioblastoma as it relates to survival. This study will examine survival in relationship to variation in several thousand polymorphisms in potentially relevant genes and chromosomal regions. Survival information related to some of these factors, such as inherited variation I metabolism and DNA repair, might be useful to clinicians in planning and refining treatments.
In June 2004, NBTF sponsored a Brain Tumor Etiology Consortium meeting of international researchers searching for causes of adult brain tumors. The meeting was organized by the Central Brain Tumor Registry of the U.S. (CBTRUS). The short-term goal of the meeting was the establishment of three research groups focusing on adult genetic/environmental susceptibility and brain tumor linkage. The long-term goal is the development of research that could successfully compete for extramural NIH grant support. The next meeting of the consortium will be held at the SNO meeting in November in Toronto. For more information about this consortium, please contact Rob Tufel at NBTF (415-834-9970 or gro.romutniarb@lefut).
The Brain Tumor Epidemiology Consortium (BTEC) is a self-directing group of population researchers committed to developing multicenter, interdisciplinary collaborations to advance our understanding of etiology, outcomes, and prevention of brain tumors. The BTEC nucleus formed at a 2002 National Cancer Institute–sponsored meeting to further molecular epidemiology studies of brain tumors based on gene-environment interactions. We subsequently expanded the group’s international representation and its representation of pediatric researchers and formulated action plans in four areas: adult gliomas, pediatric tumors, family studies, and meningiomas. BTEC meetings are set for November 18, 2004, at the SNO Annual Meeting and for May 2005 at the World Federation of Neuro-Oncology meeting. The planning committee (Jill Barnholtz-Sloan, Melissa Bondy, Faith Davis, Peter Inskip, Carol Kruchko, and Susan Preston-Martin) thanks the many individuals who have supported this initiative. In particular, we acknowledge the financial support of the NBTF and the Pediatric Brain Tumor Foundation of the United States and the organizational support of the CBTRUS and the Healing Exchange Brain Trust. Individuals who wish to know more about BTEC activities should contact Faith Davis ( ude.ciu@deyaf) or Melissa Bondy ( gro.nosrednadm@ydnobm).
The NBTF is launching a free National Brain Tumor Caregiver Program this fall, consisting of day-long workshops offered to family caregivers of brain tumor patients. These workshops teach practical skills and include topics such as managing symptoms at home, legal issues, understanding cognitive and behavior changes, and end-of-life issues.
Contact: Harriet Patterson, National Brain Tumor Foundation
Telephone: 415-834-9970, ext. 103
The Brain Tumor Society will hold a symposium and annual meeting at the Boston Newton Marriott. Keynote speakers are Dr. Henry Friedman and Dr. Robert Martuza.
Contact: Sarah Duggan, Director of Education and Support
Web site: www.tbts.org
The ninth annual meeting of the Society for Neuro-Oncology will be held in Toronto. For details, see the Call for Abstracts in the April issue of this journal or the information online (www.soc-neuro-onc.org or www.dukeupress.edu/neuro-oncology).
The second quadrennial meeting of the World Federation of Neuro-Oncology, in conjunction with the sixth European Association for Neuro-Oncology meeting (WFNO-II/EANO-VI), will be held at the Edinburgh International Conference Centre in The Exchange district, at the center of Edinburgh. The Advance Programme and the registration and accommodation booking forms for the WFNO-II/EANO-VI conference are available at the Web site. The abstract deadline is December 1, 2004. Online registration is available at the Web site. Early registration ends on January 6, and late registration ends on April 1. See our advertisement in this issue.
Contact: WFNO-II/EANO-VI Conference Secretariat Federation of European Cancer Societies Conference Unit Avenue E. Mounier 83 B-1200 Brussels, Belgium
The Thirteenth World Congress of Neurological Surgery, coinciding with the fiftieth anniversary of the World Federation of Neurosurgical Societies, will take place in Marrakesh from June 19 to 24, 2005. The congress will be hosted by the Moroccan Society of Neurosurgery and the Pan African Association of Neurological Sciences.
Abdeslam El Khamlichi, M.D., President, Thirteenth World Congress of Neurological Surgery
Abdessamad El Azhari, M.D., Chairman, Scientific Program Committee
Edward R. Laws, M.D., F.A.C.S., President, World Federation of Neurosurgical Societies
Contact: The Congress Secretariat, 13th World Congress of Neurological Surgery Hôpital des Spécialités, Department of Neurosurgery P.O. Box 6444 Rabat-Instituts Rabat, Morocco
Web site: www.marrakesh2005.org
The Second International CNS Germ Cell Tumor Conference will be held at Univeral City in Los Angeles. The conference organizer is Jonathan L. Finlay, M.D.